The transcription factor Bcl11a is essential for B-1a cell maintenance during aging

S Shasha Xu (Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University) L Liangfeng Huang (Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Anesthesiology and Perioperative medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University) X Xingjie Liu (Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University) L Linlin Zhang (Department of Applied Chemistry, Petroleum and Chemical Industry Key Laboratory of Organic Electrochemical Synthesis, State Key Laboratory of Green Chemical Synthesis and Conversion) J Jing Wang (Hunan Cancer Hospital Changsha China) Y Yifeng Hu (Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University) Y Yi Yang X Xiaojie Shi (State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University) C Chaohong Liu (Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology) R Rong Wang Z Zhichao Miao Y Yong Yu

Abstract

B-1a cells, a self-renewing B cell subset essential for innate immunity, produce natural IgM antibodies that defend against pathogens, yet mechanisms sustaining their maintenance during aging remain unclear. We report that aging B-1a cells exhibit hallmarks of decline, including DNA damage, apoptosis, and reduced proliferation, with striking sex-specific disparities: aged females retain higher B-1a cell numbers than males, correlating with enhanced glycolysis and chromatin accessibility. Motif analysis of accessible regions identified the transcription factor Bcl11a, which shows elevated chromatin accessibility and expression in aged female B-1a cells but declines in males. Bcl11a deletion reduced B-1a cell numbers, impaired viability, and increased apoptosis across sexes and ages. Mechanistically, Bcl11a sustains survival by upregulating antiapoptotic genes ( Mcl1 , Mdm2 , and Mdm4 ) to suppress p53-mediated apoptosis, as evidenced by partial rescue of viability defects in Bcl11a-deficient B-1a cells upon p53 deletion. Conversely, Bcl11a overexpression or Bcl11a-high B-1a cells from aged Bcl11a -eGFP reporter mice enhanced stress resistance. These findings establish Bcl11a as a key regulator of B-1a cell maintenance during aging and reveal its role in mitigating sex-dimorphic immune decline through transcriptional control of survival pathways.

Article Details

Volume / Issue Vol. 122, Issue 27
Published July 08, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (12)

S

Shasha Xu

Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University

L

Liangfeng Huang

Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Anesthesiology and Perioperative medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University

X

Xingjie Liu

Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University

L

Linlin Zhang

Department of Applied Chemistry, Petroleum and Chemical Industry Key Laboratory of Organic Electrochemical Synthesis, State Key Laboratory of Green Chemical Synthesis and Conversion

J

Jing Wang

Hunan Cancer Hospital Changsha China

Y

Yifeng Hu

Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University

Y

Yi Yang

X

Xiaojie Shi

State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University

C

Chaohong Liu

Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology

R

Rong Wang

Z

Zhichao Miao

Y

Yong Yu